KCP
JAZZ icon

Kera Capital Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Kera Capital Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$409K Buy
2,165
+121
+6% +$21.1K 0.05% 309
2025
Q4 		$336K Buy
+2,044
New +$313K 0.04% 367
2025
Q2 		– Sell
-1,891
Closed -$235K – 360
2025
Q1 		$235K Sell
1,891
-445
-19% -$58.1K 0.07% 155
2024
Q4 		$288K Buy
+2,336
New +$275K 0.08% 83

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Kera Capital Partners's JAZZ Position: Q1 2026 in Review

Kera Capital Partners increased its Jazz Pharmaceuticals (JAZZ) stake by 5.9% in Q1 2026, buying an estimated $21.1K and bringing the position to 2,165 shares worth $409K. The position accounts for 0.05% of the portfolio, ranked #309.

Kera Capital Partners first reported a position in JAZZ in Q4 2024 and has held it in 4 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Kera Capital Partners held 2,165 shares of Jazz Pharmaceuticals worth $409K as of Q1 2026.
  • Kera Capital Partners bought 121 Jazz Pharmaceuticals shares in Q1 2026, an estimated $21.1K.
  • Jazz Pharmaceuticals made up 0.05% of Kera Capital Partners's portfolio in Q1 2026, its #309 holding.
  • Kera Capital Partners first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Kera Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.